HLA-DR expression in B-cell non-Hodgkin's malignant lymphomas: a multiparameter flow cytometry study

Area of Science:

• Immunology
• Hematopathology
• Cell Biology

Background:

• Distinguishing between reactive lymphoid hyperplasia and B-cell lymphomas is crucial for accurate diagnosis.
• B-cell non-Hodgkin's malignant lymphomas exhibit diverse cellular and immunophenotypic characteristics.
• Multiparameter flow cytometry is a valuable tool for B-cell immunophenotyping.

Purpose of the Study:

• To investigate the utility of HLA-DR expression patterns in differentiating B-cell malignant lymphomas.
• To assess the correlation between HLA-DR distribution and cell type in B-cell lymphomas.
• To evaluate the potential of flow cytometry for classifying B-cell lymphomas.

Main Methods:

• Analysis of 10 cases of reactive follicular hyperplasia and 31 cases of B-cell non-Hodgkin's malignant lymphoma.
• Application of multiparameter flow cytometry to assess HLA-DR expression, surface immunoglobulin, and B cell-specific antigens (CD19, CD20).
• Statistical analysis to determine the significance of HLA-DR distribution in classifying lymphoma subtypes.

Main Results:

• A bimodal HLA-DR distribution was frequently observed in mixed cell type B-cell lymphomas and infrequently in non-mixed cell types.
• HLA-DR distribution alone allowed for the separation of B-cell lymphomas into mixed and non-mixed cell types with high accuracy (P = 0.0001).
• Correlation between low HLA-DR and small cells, and high HLA-DR and large cells was noted in follicular, mixed-cell type lymphomas.

Conclusions:

• HLA-DR expression patterns, particularly bimodal distribution, can effectively differentiate most mixed cell type B-cell lymphomas from other B-cell lymphomas.
• This immunophenotypic marker offers a valuable approach for subtyping B-cell malignant lymphomas.
• Further investigation into exceptional cases may refine diagnostic criteria.